pharmaceutical investing Aquestive Therapeutics Announces Resubmission of New Drug Application to FDA for Anaphylm Sublingual Film
pharmaceutical investing Aquestive Therapeutics to Participate in Upcoming September Investor Conferences
pharmaceutical investing Aquestive Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
pharmaceutical investing Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm Sublingual Film
pharmaceutical investing Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET
pharmaceutical investing Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
pharmaceutical investing Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
pharmaceutical investing Aquestive Therapeutics to Report First Quarter 2026 Financial Results and Recent Business Highlights on May 13 and Host Conference Call on May 14 at 8:00 a.m. ET
SAGA Metals Reports Final Titanium, Vanadium and Iron Assays from MRE Drilling--Maiden Mineral Resource Estimate Imminent
Lahontan Gold Announces Updated Santa Fe Preliminary Economic Assessment Featuring an Eleven-Year Mine Life and Post-Tax NPV5 of US$820 Million
QIMC Completes Expanded 63.7 km Seismic Program Targeting Hydrogen, Helium and Natural Gas Hot Zones in Nova Scotia
Pan Global Expands Near-Surface High-Grade Gold Discovery at Cármenes Project, Spain: Drillholes Return 7.29g/t Au Over 9 Meters and 1.53g/t Au Over 38 Meters
SAGA Metals Reports Final Titanium, Vanadium and Iron Assays from MRE Drilling-Maiden Mineral Resource Estimate Imminent
